Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07468877 · ClinicalTrials.gov registry record · NA
This Clinical Trial Compares Two Phacoemulsification Systems Used in a Bilateral Cataract Surgery Subjects in Order to Study CDE and Ultrasound Time During Cataract Removal
A NA study of Phacoemulsification Cataract Surgery and Cataract Bilateral, sponsored by Nicole Fram M.D..
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT07468877: Recruiting NA study of Phacoemulsification Cataract Surgery and Cataract Bilateral, sponsored by Nicole Fram M.D..
NCT07468877 is a NA study of Phacoemulsification Cataract Surgery and Cataract Bilateral that is actively recruiting participants, run by Nicole Fram M.D.. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07468877, a NA study of Phacoemulsification Cataract Surgery and Cataract Bilateral, is actively recruiting participants, sponsored by Nicole Fram M.D..
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial compares two phacoemulsification systems used in a bilateral cataract surgery subjects, in order to study CDE and Ultrasound time during cataract removal
Primary Outcome
CDE is a measure of the total ultrasound energy delivered into the eye during phacoemulsification cataract surgery
Conditions Studied
Interventions
- DEVICE Cataract extraction with phacoemulsification comparing two systems
Study Locations (1)
California
- Advanced Vision Care - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2026-02-13 |
| Est. Completion | 2027-02-13 |
| Phase | NA |
What NCT07468877 shows while recruiting
NCT07468877 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 3 conditions, with Phacoemulsification Cataract Surgery appearing as the primary indexed condition, and to 1 intervention - of which Cataract extraction with phacoemulsification comparing two systems is the first listed.
NCT07468877 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT07468877 about?
NCT07468877 is a clinical study titled "This Clinical Trial Compares Two Phacoemulsification Systems Used in a Bilateral Cataract Surgery Subjects in Order to Study CDE and Ultrasound Time During Cataract Removal". This clinical trial compares two phacoemulsification systems used in a bilateral cataract surgery subjects, in order to study CDE and Ultrasound time during cataract removal
What is the current status of trial NCT07468877?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2026-02-13. Estimated completion is 2027-02-13.
What conditions does trial NCT07468877 study?
This clinical trial studies the following conditions: Phacoemulsification Cataract Surgery, Cataract Bilateral, Nuclear Sclerosis of the Lens.
What interventions are being tested in trial NCT07468877?
The interventions under investigation include: Cataract extraction with phacoemulsification comparing two systems (DEVICE).
Who is sponsoring clinical trial NCT07468877?
This trial is sponsored by Nicole Fram M.D., which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07468877 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Phacoemulsification Cataract Surgery
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07468877's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI